BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35199933)

  • 1. Dexmedetomidine inhibits the growth and metastasis of esophageal cancer cells by down-regulation of lncRNA MALAT1.
    Zhang W; Zhang L; Cai XJ; Li D; Cao FJ; Zuo ZG; Song Y; Yu XJ; Liu S
    Kaohsiung J Med Sci; 2022 Jun; 38(6):585-593. PubMed ID: 35199933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanism of long non-coding RNA-metastasis associated lung adenocarcinoma transcript 1 induced invasion and metastasis of esophageal cancer cell EC-109].
    Zhang QQ; Cui YH; Wang Y; Kou WZ; Cao F; Cao XJ; Miao ZH; Kang XH
    Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):405-411. PubMed ID: 28635228
    [No Abstract]   [Full Text] [Related]  

  • 3. Suppression of long non-coding RNA MALAT1 inhibits survival and metastasis of esophagus cancer cells by sponging miR-1-3p/CORO1C/TPM3 axis.
    Li Q; Dai Z; Xia C; Jin L; Chen X
    Mol Cell Biochem; 2020 Jul; 470(1-2):165-174. PubMed ID: 32468237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA MALAT1 promotes epithelial-to-mesenchymal transition of esophageal cancer through Ezh2-Notch1 signaling pathway.
    Chen M; Xia Z; Chen C; Hu W; Yuan Y
    Anticancer Drugs; 2018 Sep; 29(8):767-773. PubMed ID: 29916899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MALAT1/miR-124/Capn4 axis regulates proliferation, invasion and EMT in nasopharyngeal carcinoma cells.
    Shi B; Wang Y; Yin F
    Cancer Biol Ther; 2017 Oct; 18(10):792-800. PubMed ID: 28857668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA MALAT1 regulates trophoblast cells migration and invasion via miR-206/IGF-1 axis.
    Wu HY; Wang XH; Liu K; Zhang JL
    Cell Cycle; 2020 Jan; 19(1):39-52. PubMed ID: 31774373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing of long noncoding RNA MALAT1 by miR-101 and miR-217 inhibits proliferation, migration, and invasion of esophageal squamous cell carcinoma cells.
    Wang X; Li M; Wang Z; Han S; Tang X; Ge Y; Zhou L; Zhou C; Yuan Q; Yang M
    J Biol Chem; 2015 Feb; 290(7):3925-35. PubMed ID: 25538231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA MALAT1 enhances the protective effect of dexmedetomidine on acute lung injury by sponging miR-135a-5p to downregulate the ratio of X-box binding proteins XBP-1S/XBP-1U.
    Li P; Gu L; Bian Q; Jiao D; Xu Z; Wang L
    Bioengineered; 2021 Dec; 12(1):6377-6389. PubMed ID: 34516310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexmedetomidine represses proliferation and promotes apoptosis of esophageal cancer cells by regulating C-Myc gene expression via the ERK signaling pathway.
    Hu Y; Qiu LL; Zhao ZF; Long YX; Yang T
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):950-956. PubMed ID: 33577050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of Long Noncoding RNA (lncRNA) Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Inhibits Proliferation, Migration, and Invasion and Promotes Apoptosis by Targeting miR-124 in Retinoblastoma.
    Liu S; Yan G; Zhang J; Yu L
    Oncol Res; 2018 May; 26(4):581-591. PubMed ID: 28550678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long Non-Coding RNA MALAT1 Protects Human Osteoblasts from Dexamethasone-Induced Injury via Activation of PPM1E-AMPK Signaling.
    Fan JB; Zhang Y; Liu W; Zhu XH; Xu DW; Zhao JN; Cui ZM
    Cell Physiol Biochem; 2018; 51(1):31-45. PubMed ID: 30439702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Noncoding RNA MALAT1 Regulates Hepatocellular Carcinoma Growth Under Hypoxia via Sponging MicroRNA-200a.
    Zhao ZB; Chen F; Bai XF
    Yonsei Med J; 2019 Aug; 60(8):727-734. PubMed ID: 31347327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma.
    Hu L; Wu Y; Tan D; Meng H; Wang K; Bai Y; Yang K
    J Exp Clin Cancer Res; 2015 Jan; 34(1):7. PubMed ID: 25613496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depletion of lncRNA MALAT1 inhibited sunitinib resistance through regulating miR-362-3p-mediated G3BP1 in renal cell carcinoma.
    Wang Z; Chang X; Zhu G; Gao X; Chang L
    Cell Cycle; 2020 Aug; 19(16):2054-2062. PubMed ID: 32663095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Chain Non-Coding RNA Metastasis-Related Lung Adenocarcinoma Transcript 1 (MALAT1) Promotes the Proliferation and Migration of Human Pulmonary Artery Smooth Muscle Cells (hPASMCs) by Regulating the MicroRNA-503 (miR-503)/Toll-Like Receptor 4 (TLR4) Signal Axis.
    He M; Shen J; Zhang C; Chen Y; Wang W; Tao K
    Med Sci Monit; 2020 Jul; 26():e923123. PubMed ID: 32712618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA-MALAT1 promotes tumorogenesis of infantile hemangioma by competitively binding miR-424 to stimulate MEKK3/NF-κB pathway.
    Li MM; Dong CX; Sun B; Lei HZ; Wang YL; Gong YB; Sun LL; Sun ZW
    Life Sci; 2019 Dec; 239():116946. PubMed ID: 31610202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The knockdown of MALAT1 inhibits the proliferation, invasion and migration of hemangioma endothelial cells by regulating MiR-206 / VEGFA axis.
    Wang S; Ren L; Shen G; Liu M; Luo J
    Mol Cell Probes; 2020 Jun; 51():101540. PubMed ID: 32084582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA H19 promotes epithelial mesenchymal transition and metastasis of esophageal cancer via STAT3/EZH2 axis.
    Chen MJ; Deng J; Chen C; Hu W; Yuan YC; Xia ZK
    Int J Biochem Cell Biol; 2019 Aug; 113():27-36. PubMed ID: 31102664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA HOTAIR functions as miRNA sponge to promote the epithelial to mesenchymal transition in esophageal cancer.
    Xu F; Zhang J
    Biomed Pharmacother; 2017 Jun; 90():888-896. PubMed ID: 28441714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexmedetomidine suppresses the progression of esophageal cancer via miR-143-3p/epidermal growth factor receptor pathway substrate 8 axis.
    Zhang P; He H; Bai Y; Liu W; Huang L
    Anticancer Drugs; 2020 Aug; 31(7):693-701. PubMed ID: 32701250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.